sk1 [Company Analysis] SK Biopharm. SK Biopharm analysis. SK Biopharm Samsung Biologics Comparison Hello everyone, this is diversity from Korea. Finally, the company that everyone was expecting appeared in the Korean Nasdaq, KOSPI. SK Bio pharm. If it were the same as before, I wouldn't have had much hope for it. However, as the market was becoming speculative, there were companies that could see that there was no better speculative property. Some believe in and invest in the future of SK Bio.. 2020. 7. 4. 이전 1 다음
